Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding HAL photodynamic therapy in cervical intraepithelial neoplasia
2010-023903-91Phase 2Completed
- Sponsor
- Photocure
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of hexaminolevulinate in cervical intraepithelial neoplasia (CIN) and cervical intraepithelial neoplasia grade 1 (4 arms), sponsored by Photocure. Primary endpoint: Primary response at 3 months after one treatment. Started Feb 2011; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
cervical intraepithelial neoplasia (CIN)cervical intraepithelial neoplasia grade 1
Beyond the preview
Go deeper on 2010-023903-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023903-91.